Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
CE8-H82E9 | Human | Biotinylated Human CEACAM-8 / CD66b Protein, His,Avitag™ | ![]() |
![]() ![]() |
![]() ![]() |
CE8-H5224 | Human | Human CEACAM-8 / CD66b Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Besilesomab | BW-250-183; 99Tcm-BW250-183; TLX-66-CDx; TLX66-CDx | Approved | Cis Bio International Sa | Scintimun | EU | Osteomyelitis | Cis Bio International Sa | 2010-01-11 | Osteomyelitis | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
90Y-DTPA-besilesomab | TLX-66 | Phase 2 Clinical | Telix Pharmaceuticals Ltd | Multiple Myeloma; Neoplasms, Plasma Cell | Details |
This web search service is supported by Google Inc.